Work

Factors Associated with Real-World Multitarget Stool DNA Test Adherence and Follow-up Colonoscopy Completion in a California Healthcare System

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Colorectal cancer (CRC) is highly treatable when diagnosed early, but screening benefit depends on completing both initial testing and follow-up colonoscopy (FU-CY) after a positive stool-based test. Objectives: As quality measurements increasingly emphasize FU-CY after positive noninvasive CRC screening results, this study evaluated factors associated with multitarget stool DNA (mt-sDNA) adherence and FU-CY completion within the Providence Healthcare System in California. Methods: This retrospective cohort study linked laboratory data from Abbott with administrative claims data from Komodo Health. The study population included mt-sDNA tests shipped to patients between July 2016 and June 2023. Adherence was defined as return of a completed test with a valid result within one year of shipment. Completion of FU-CY was defined as the first eligible colonoscopy claim occurring within 1 year of a positive mt-sDNA result. Multivariable logistic regression was used to identify factors associated with mt-sDNA adherence. Among test kits with a positive mt-sDNA finding, factors associated with time to FU-CY were evaluated using Cox proportional hazards regression. Results: Of 6191 mt-sDNA test kits, 4766 (77.0%) were completed within 1 year. Higher adjusted odds of adherence were observed among males, among patients with commercial, Medicare Advantage, or traditional Medicare insurance compared with Medi-Cal; among patients with prior mt-sDNA use; among gastroenterologist-ordered tests; and among those receiving full digital or SMS-only outreach. Among 560 patients with positive mt-sDNA results, who met the continuous enrollment requirement, 394 (70.4%) completed FU-CY within 1 year. Gastroenterologist-ordered tests were associated with shorter time to FU-CY completion (adjusted hazard ratio, 2.26; 95% CI, 1.31-3.88). Discussion: High mt-sDNA screening adherence and FU-CY completion were observed in this California-based Providence cohort, although adherence varied across patient and healthcare delivery characteristics. These results suggest that both demographic and healthcare delivery factors influence the effectiveness of screening programs. Conclusions: These findings suggest that modifiable healthcare delivery strategies, including digital reminders, and coordinated follow-up pathways, may support participation and diagnostic continuity in stool-based CRC screening programs.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W7236818218
FWCI:
Cites: 35
Cited by:
Related to: 10